(BUSINESS WIRE )--Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company's Lumipulse ® G pTau 217/β-Amyloid 1-42 Plasma Ratio in ...

MALVERN, Pa., & TOKYO — Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse ® G pTau 217/β-Amyloid 1-42 Plasma Ratio ...

The new additions to the CNS Disease 120 Panel are specifically designed to detect brain-derived forms of pTau, overcoming the limitations of current assays that cannot distinguish between ...

The ability to detect brain-derived pTau species directly from blood represents a transformative step in early detection Phosphorylated tau has emerged as a critical biomarker for early detection ...

The pTau 217 Blood Test is something that’s been worked on for years at ARUP Laboratories on the University of Utah’s campus. “We need to make sure that the performance characteristics of ...

SALT LAKE CITY, April 21, 2025 /PRNewswire/ -- ARUP Laboratories now provides a blood test for phosphorylated tau 217 (pTau 217) to assist in identifying whether cognitive decline symptoms in ...